Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Digifab Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ResearchAndMarkets.com's offering. This ...

The UMSOM researchers hypothesize that DigiFab ® could prevent kidney injury by binding to ouabain iv,v. This study examines whether providing DigiFab ®?will reduce ouabain levels and lower the risk ...

Protherics of the UK says that it has put forward a New Drug Submission to the Health Products and Food Branch of Health Canada for DigiFab, its digoxin toxicity drug. Protherics of the UK says that ...

Melville, NY - Savage Laboratories has announced the introduction of DigiFab? (digoxin immune fab [Ovine]), a digoxin toxicity antidote, to the US marketplace. The drug has been determined by the FDA ...

DigiFab® 40 mg/vial digoxin immune Fab, Powder for solution for infusion (hereafter referred to as DigiFab®) Launched in the UK London, UK, 28 March 2012: BTG, the specialist healthcare company today ...

BTG plc , the specialty pharmaceuticals company, announces that it has signed an agreement with Nycomed US Inc. concerning the accelerated transition to BTG on October 1, 2010 of marketing rights to ...

Paladin Labs Inc. has announced the Canadian launch of DigiFab™ Digoxin Immune Fab (Ovine). DigiFab™ is indicated for the treatment of patients with life-threatening or potentially life-threatening ...

(MENAFN- GlobeNewsWire - Nasdaq) The Key player in the digifab market is SERB Pharmaceuticals. North America was the largest region in the digifab market in 2024. The digifab market consists of sales ...